Stocktoria

Tenaya Therapeutics, Inc. TNYA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-30

Tenaya Therapeutics, Inc. statistics & valuation

Market cap$155.7M
P / B1.3×
Return on equity-73.5%
Return on capital-71%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-26.10% -50.80% -89.00% -119.70% -73.50% 202020212022202320242025
Shares outstanding
1.2M 41.3M 66.9M 73.8M 86.5M 216.8M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-25.90% -23.10% -44.30% -72.80% -92.70% -61.70% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$4.10 -$2.76 -$1.68 -$1.31 -$0.59 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-61.7%-92.7%-72.8%-44.3%-23.1%-25.9%
Return on equity-73.5%-119.7%-89.0%-50.8%-26.1%47.2%
Current ratio6.844.224.917.9911.7325.78

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.